Literature DB >> 11738227

An evaluation of symptom classification systems used for the assessment of patients with heart failure in France.

P Gibelin1.   

Abstract

Many systems have been proposed to assess the degree of functional impairment in patients with chronic heart failure in order to be able to draw comparisons between patients and assess the development of the disease in the same patient. The NYHA classification is subjective and insufficiently reproducible and has no real predictive value with respect to the exertion test. The Canadian classification does not contribute much in terms of validation. The Feinstein and Duke University classifications are too complex, not very easy to use and have never been validated. The scale of activity proposed by Goldman gives details on functional impairment by using examples from daily activities, selected for their variety and grouped according to the energy that they require. This classification is highly reproducible and is concordant with the exertion test (duration of the exertion test, VO2 max). However, it is not suitable for France. The examples are not precise enough: in addition, they do not eliminate contradictions that can make the patient impossible to classify. We propose a scale of activity specifically designed for use in France. It is reproducible and the VO2 peaks are highly concordant. Lastly, the questions the patient is asked are progressive, thus avoiding contradictory answers. This classification could prove to be useful in everyday life and also for multi-center studies in French-speaking countries.

Entities:  

Mesh:

Year:  2001        PMID: 11738227     DOI: 10.1016/s1388-9842(01)00206-9

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  4 in total

1.  Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies.

Authors:  A Verma; F Kilicaslan; D O Martin; S Minor; R Starling; N F Marrouche; S Almahammed; O M Wazni; S Duggal; R Zuzek; H Yamaji; J Cummings; M K Chung; P J Tchou; A Natale
Journal:  Heart       Date:  2005-05-27       Impact factor: 5.994

2.  A clinical study of pattern and factors affecting outcome in Nigerian patients with advanced heart failure.

Authors:  O B Familoni; T O Olunuga; B W Olufemi
Journal:  Cardiovasc J Afr       Date:  2007-10-22       Impact factor: 1.167

3.  Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review.

Authors:  Gian Luca Di Tanna; Anna Bychenkova; Frank O'Neill; Heidi S Wirtz; Paul Miller; Briain Ó Hartaigh; Gary Globe
Journal:  Pharmacoeconomics       Date:  2019-03       Impact factor: 4.981

4.  Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF.

Authors:  Phil McEwan; Oliver Darlington; John J V McMurray; Pardeep S Jhund; Kieran F Docherty; Michael Böhm; Mark C Petrie; Klas Bergenheim; Lei Qin
Journal:  Eur J Heart Fail       Date:  2020-09-15       Impact factor: 15.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.